Impact of baseline antiretroviral resistance status on efficacy outcomes among patients receiving maraviroc plus optimized background therapy in the MOTIVATE 1 and 2 trials

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: The MOTIVATE studies assessed maraviroc with optimized background therapy (OBT) in treatment-experienced patients with R5 HIV-1. This post hoc analysis compared outcomes between patients with and without HIV-1 resistance to ε3 classes of antiretrovirals at screening (triple-class-resistant [TCR] versus not-TCR [nTCR]). Methods: Week 48 changes (N = 635) in HIV-1 RNA and CD4 + cells were compared between TCR and nTCR groups receiving twice-daily maraviroc+OBT or placebo+OBT. Results: HIV-1 RNA change from baseline on maraviroc was significantly greater in the nTCR group (-2.05 vs -1.74 log 10 copies/mL; 95% CI difference 0.05-0.58 log10) though proportions <400 or <50 copies/mL were not. Week 48 CD4 increases were significantly greater in the nTCR group overall (mean +150 vs +110 cells/mm 3; 95% CI difference 18-62 cells/mm3) and in those with <50 RNA copies/mL (nTCR +192 vs +126 cells/mm3; 95% CI difference, 19-93 cells/mm3) or receiving ≥2 active OBT agents (weighted score; nTCR +184 vs +125 cells/mm3; 95% CI difference 8-110 cells/mm3). Conclusions: Virologic suppression on maraviroc was greater in the nTCR than the TCR group, though proportions <50 or 400 copies/mL were not significantly different. Optimal CD4 increases on maraviroc appeared to accrue from initiation before development of TCR virus. © 2010 Thomas Land Publishers, Inc.

Cite

CITATION STYLE

APA

Nelson, M., Fisher, M., Gonzalez-Garcia, J., Rockstroh, J. K., Weinstein, D., Valdez, H., … Dang, N. (2010). Impact of baseline antiretroviral resistance status on efficacy outcomes among patients receiving maraviroc plus optimized background therapy in the MOTIVATE 1 and 2 trials. HIV Clinical Trials, 11(3), 145–155. https://doi.org/10.1310/hct1103-145

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free